The Board of Directors of Antisense Therapeutics Limited announced the appointment of Dr. Gil Price, Antisense Therapeutics' US-based Consultant Medical Director to the Company's board as a non-executive director. Dr. Gil Price's appointment is effective immediately and will be confirmed with shareholders following the 2021 Annual General Meeting at which time William Goolsbee, current non-executive director of ANP will retire from the Board of Directors.